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Summary. Alterations in methylation are widespread in 
cancers. DNA methylation of promoter-associated CpG 
islands is an alternate mechanism to mutation in 
silencing gene function, and affects tumor-suppressor 
genes such as p16 and RBI, growth and differentiation 
controlling genes such as ER and many others. Evidence 
is now accumulating that some of these methylation 
changes may initiate in subpopulations of normal cells as 
a function of age and progressively increase during 
carcinogenesis. Age-related methylation appears to be 
widespread and is one of the earliest changes marking 
the risk for neoplasia. In colon cancer, we have shown a 
pattern of age-related methylation for several genes, 
including ER, IGF2, N33 and MyoD, which progresses 
to full methylation in adenomas and neoplasms. 
Hypermethylation of these genes is associated with gene 
silencing. Age-related methylation involves at least 50% 
of the genes which are hypermethylated in colon cancer, 
and we propose that such age-related methylation may 
partly account for the fact that most cancers occur as a 
function of old age. Age-related methylation, then, may 
be a fundamental mark of the field defect in patients 
with neoplasia. The causes of age-related methylation 
are still unknown at this point, but evidence points to an 
interplay between local predisposing factors in DNA 
(methylation centers), levels of gene expression and 
environmental exposure. The concept that age-related 
methylation is a predisposing factor for neoplasia 
implies that it may serve as a diagnostic risk marker in 
cancer, and as a novel target for chemoprevention. 
Studies in animal models support this hypothesis and 
should lead to novel approaches to risk-assessment and 
chemoprevention in humans. 
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Introduction 
In recent years, DNA methylation has garnered a lot 
of attention because of its importance in normal 
embryonic development and its involvement in 
carcinogenesis. Widespread changes in methylation 
patterns have been noted to occur during carcinogenesis 
as well as during normal development for the past 
twenty years (Jones, 1996; Baylin et al. ,  1998). 
However, the exact function of the process of DNA 
methylation in the human genome has been much 
debated during this time, and only recently have some of 
these functions been elucidated. DNA methylation has 
been shown to be essential in normal embryogenesis and 
development, a s  well as  critical in silencing the 
expression of some tumor-suppressor genes during 
tumorigenesis. 
This review will provide a basic overview of DNA 
methylation and its role in cancer, with a particular focus 
on DNA methylation in normal aging and how this may 
contribute to tumorigenesis. 
DNA methylation and CpG Islands 
DNA methylation refers to a post-replicative 
modification by which DNA residues acquire a 
covalently bound methyl group. DNA methylation is 
present in most organisms, including bacteria, plants and 
humans, but is absent in organisms such as Drosophila 
and Caenorhabdit is  elegans. In mammals, DNA 
methylation only occurs at cytosine residues found 
within CpG dinucleotides and involves methylation of 
the 5 position of cytosine (C) leading to the formation of 
5-methylcytosine (5-mC). DNA methylation is mediated 
by the enzyme DNA methyltransferase (Mtase) and uses 
S-Adenosylmethionine as a methyl donor (Bestor and 
Verdine, 1994). Cytosine methylation, in fact, is the only 
known naturally occurring modification of DNA in 
higher eukaryotes and 5-mC has been referred to as the 
fifth base. This  modification is referred to as an 
epigenetic change since i t  does not alter the primary 
DNA sequence. 
The CpG dinucleotide is suppressed in higher order 







